Larsen RH - Search Results

1

Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates.

Dahle J, Abbas N, Bruland ØS, Larsen RH. Dahle J, et al. Curr Radiopharm. 2011 Oct;4(4):321-8. doi: 10.2174/1874471011104040321. Curr Radiopharm. 2011. PMID: 22202154 Review.

2

Inactivation of human osteosarcoma cells in vitro by 211At-TP-3 monoclonal antibody: comparison with astatine-211-labeled bovine serum albumin, free astatine-211 and external-beam X rays.

Larsen RH, Bruland OS, Hoff P, Alstad J, Lindmo T, Rofstad EK. Larsen RH, et al. Radiat Res. 1994 Aug;139(2):178-84. Radiat Res. 1994. PMID: 8052693

3

Exposure of human osteosarcoma and bone marrow cells to tumour-targeted alpha-particles and gamma-irradiation: analysis of cell survival and microdosimetry.

Aurlien E, Larsen RH, Akabani G, Olsen DR, Zalutsky MR, Bruland OS. Aurlien E, et al. Int J Radiat Biol. 2000 Aug;76(8):1129-41. doi: 10.1080/09553000050111604. Int J Radiat Biol. 2000. PMID: 10947126

4

Demonstration of highly specific toxicity of the alpha-emitting radioimmunoconjugate(211)At-rituximab against non-Hodgkin's lymphoma cells.

Aurlien E, Larsen RH, Kvalheim G, Bruland OS. Aurlien E, et al. Br J Cancer. 2000 Nov;83(10):1375-9. doi: 10.1054/bjoc.2000.1453. Br J Cancer. 2000. PMID: 11044364 Free PMC article.

5

Evaluation of potential chelating agents for radium.

Henriksen G, Hoff P, Larsen RH. Henriksen G, et al. Appl Radiat Isot. 2002 May;56(5):667-71. doi: 10.1016/s0969-8043(01)00282-2. Appl Radiat Isot. 2002. PMID: 11993940

6

Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model.

Henriksen G, Breistøl K, Bruland ØS, Fodstad Ø, Larsen RH. Henriksen G, et al. Cancer Res. 2002 Jun 1;62(11):3120-5. Cancer Res. 2002. PMID: 12036923

7

Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice.

Henriksen G, Fisher DR, Roeske JC, Bruland ØS, Larsen RH. Henriksen G, et al. J Nucl Med. 2003 Feb;44(2):252-9. J Nucl Med. 2003. PMID: 12571218

8

Thorium and actinium polyphosphonate compounds as bone-seeking alpha particle-emitting agents.

Henriksen G, Bruland OS, Larsen RH. Henriksen G, et al. Anticancer Res. 2004 Jan-Feb;24(1):101-5. Anticancer Res. 2004. PMID: 15015582

9

Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides.

Henriksen G, Schoultz BW, Michaelsen TE, Bruland ØS, Larsen RH. Henriksen G, et al. Nucl Med Biol. 2004 May;31(4):441-9. doi: 10.1016/j.nucmedbio.2003.11.004. Nucl Med Biol. 2004. PMID: 15093814

10

Preparation and preclinical assessment of folate-conjugated, radiolabelled antibodies.

Henriksen G, Bruland OS, Larsen RH. Henriksen G, et al. Anticancer Res. 2005 Jan-Feb;25(1A):9-15. Anticancer Res. 2005. PMID: 15816513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results